Alphatec Holdings (ATEC) is back in focus after reporting first quarter 2026 results, with a net loss of US$33.91 million and basic loss per share of US$0.22 from continuing operations.

At a share price of US$10.23, Alphatec Holdings has seen a 9.41% 7 day share price return but a 50.72% year to date share price decline. The 1 year total shareholder return is 15.94% lower, suggesting recent momentum has faded despite interest around the Q1 2026 results and recent conference appearance.

If this earnings move has you reassessing opportunities in medical technology, it can help to scan for other healthcare companies harnessing artificial intelligence, including those in our 35 healthcare AI stocks

With the stock down sharply year to date and trading at a sizeable discount to some analysts’ price targets and intrinsic estimates, investors now face a key question: Is this weakness a potential entry point, or is the market already pricing in future growth?

Most Popular Narrative: 58.4% Undervalued

At a last close of $10.23 versus a narrative fair value of $24.62, Alphatec Holdings is framed as significantly undervalued, with that gap tied to ambitious profitability and growth assumptions.

Analysts have adjusted their Alphatec Holdings target to $24.62, reflecting updated assumptions that combine slightly lower expected revenue growth with higher projected profit margins and a reduced future P/E multiple, while applying a somewhat higher discount rate.

Curious how slower forecast revenue growth can still pair with a higher fair value? The narrative leans heavily on margin expansion and a rich future earnings multiple. Want to see which earnings and cash flow assumptions make that jump from today’s loss making profile to those targets look reasonable enough on paper?

Result: Fair Value of $24.62 (UNDERVALUED)

However, this narrative can break if spine procedure volumes soften or if larger competitors pressure pricing, which could challenge those margin and earnings assumptions.

Next Steps

With sentiment clearly split between risk and opportunity, this is a moment to act quickly and weigh the trade offs yourself by using the full 4 key rewards and 1 important warning sign

Looking for more investment ideas?

Do not stop with a single stock. Broaden your watchlist now so you are not relying on just one story to work out.

• Consider targeting resilient income by scanning companies that may sustain stronger payouts with the 13 dividend fortresses
• Look for potential value opportunities that pair quality and attractive pricing using the 51 high quality undervalued stocks
• Focus on companies with sturdier finances to help protect your capital through the solid balance sheet and fundamentals stocks screener (46 results)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.